1. |
Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature, 2011, 473(7347): 317-325.
|
2. |
Andreasen JJ, Vadmann H, Oddershede L, et al. Decreased patency rates following endoscopic vein harvest in coronary artery bypass surgery. Scand Cardiovasc J, 2015, 49(5): 286-292.
|
3. |
邱志兵, 陈鑫, 万松. 猪静脉桥血管重建中平滑肌细胞和成纤维细胞表型转化. 中国动脉硬化杂志, 2008, 16(7): 532-536.
|
4. |
Singer E, Markó L, Paragas N, et al. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf), 2013, 207(4): 663-672.
|
5. |
Kafkas N, Demponeras C, Zoubouloglou F, et al. Serum levels of gelatinase associated lipocalin as indicator of the inflammatory status in coronary artery disease. Int J Inflam, 2012, 2012: 189797.
|
6. |
Sivalingam Z, Larsen SB, Grove EL, et al. Neutrophil gelatinase-associated lipocalin as a risk marker in cardiovascular disease. Clin Chem Lab Med, 2017, 56(1): 5-18.
|
7. |
Soylu K, Aksan G, Nar G, et al. Serum neutrophil gelatinase-associated lipocalin levels are correlated with the complexity and the severity of atherosclerosis in acute coronary syndrome. Anatol J Cardiol, 2015, 15(6): 450-455.
|
8. |
Zykov MV, Kashtalap VV, Bykova IS, et al. Clinical and prognostic value of serum neutrophil gelatinase-associated lipocalin in patients with ST-segment elevation myocardial infarction. Kardiologiia, 2016, 56(5): 24-29.
|
9. |
Katagiri M, Takahashi M, DoiK, et al. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease. Heart Vessels, 2016, 31(10): 1595-1602.
|
10. |
Wan S, Shukla N, Yim AP, et al. Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts. J Thorac Cardiovasc Surg, 2007, 133(2): 494-500.
|
11. |
Wan S, Shukla N, Angelini GD, et al. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1). J Thorac Cardiovasc Surg, 2007, 134(4): 1033-1039.
|
12. |
邱志兵, 陈鑫, 万松. 血管外膜和平滑肌细胞增殖活性及胶原分布对血管重塑影响. 南京医科大学学报(自然科学版), 2008, 28(6): 752-757.
|
13. |
刘琴, 蒋洪敏. NGAL临床应用及实验室检测最新进展. 国际检验医学杂志, 2014, 35(10): 1302-1304.
|
14. |
Eilenberg W, Stojkovic S, Piechota-Polanczyk A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro. Eur J Vasc Endovasc Surg, 2016, 51(5): 623-631.
|
15. |
许丽艳, 李恩民, 熊华淇. NGAL的结构与功能研究进展. 生命科学, 2002, 14(1): 27-29.
|
16. |
Bu DX, Hemdahl AL, Gabrielsen A, et al. Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB. Am J Pathol, 2006, 169(6): 2245-2253.
|
17. |
Helanova K, Spinar J, Parenica J. Diagnostic and prognostic utility of neutrophil gelatinase-associated lipocalin (NGAL) in patients with cardiovascular diseases--review. Kidney Blood Press Res, 2014, 39(6): 623-629.
|
18. |
徐华. 颈动脉超声联合血清 MMP-9 及 APN 预测冠脉不稳定斑块的研究. 天津医科大学, 2015.
|
19. |
Raines EW. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int J Exp Pathol, 2000, 81(3): 173-182.
|
20. |
许涛, 刘和俊. 血清白介素-18、基质金属蛋白酶-9 及血浆纤维蛋白原与急性冠脉综合征冠脉病变程度的相关性研究. 安徽医药, 2016, 20(2): 308-312.
|
21. |
Kalela A, Pönniö M, Koivu TA, et al. Association of serum sialic acid and MMP-9 with lipids and inflammatory markers. Eur J Clin Invest, 2000, 30(2): 99-104.
|
22. |
DI Carlo A. Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9(MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumors. Oncol Lett, 2013, 5(5): 1677-1681.
|
23. |
葛夕洪, 杨晶, 徐锐, 等. MMP-2、MMP-9、TIMP-1 在血管成形术后再狭窄中的表达及其意义的实验研究. 中国介入影像与治疗学, 2008, 5(3): 165-169.
|
24. |
Knox JB, Sukhova GK, Whittemore AD, et al. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation, 1997, 95(1): 205-212.
|
25. |
Schwartz SM. Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest, 1997, 100(11 Suppl): S87.
|